Importantly, these neuroprotective effects are seen across multiple subtypes of ALS, including the two most common genetic subtypes caused by mutations in the C9orf72 and SOD1 genes, as well as sporadic ALS cases. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.